FIA
ENZ

FNY Investment Advisers’s Enzo Biochem, Inc. ENZ Stock Holding History

FNY Investment Advisers’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,000
Closed -$22K – 986
2024
Q3 		$22K Buy
+20,000
New +$22.4K 0.01% 394
2024
Q1 		– Sell
-75,911
Closed -$105K – 873
2023
Q4 		$105K Buy
+75,911
New +$101K 0.12% 125
2023
Q2 		– Sell
-11,003
Closed -$26K – 730
2023
Q1 		$26K Buy
+11,003
New +$16.4K 0.03% 242
2021
Q2 		– Sell
-2,000
Closed -$6K – 997
2021
Q1 		$6K Buy
+2,000
New +$6.22K ﹤0.01% 626

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

FNY Investment Advisers's ENZ Position: Q4 2024 in Review

FNY Investment Advisers sold out of Enzo Biochem, Inc. (ENZ) in Q4 2024, closing a stake of 20,000 shares — an estimated $22K sold.

FNY Investment Advisers first reported a position in ENZ in Q1 2021 and held it in 4 quarters. The position peaked at $105K in Q4 2023. 45 funds tracked by Wall St. Rank hold ENZ as of Q4 2024.

  • FNY Investment Advisers reported no remaining Enzo Biochem, Inc. position as of Q4 2024 after selling out during the quarter.
  • FNY Investment Advisers sold 20,000 Enzo Biochem, Inc. shares in Q4 2024, an estimated $22K.
  • FNY Investment Advisers first reported a position in Enzo Biochem, Inc. in Q1 2021 and held it in 4 quarters.
  • FNY Investment Advisers's Enzo Biochem, Inc. position peaked at $105K in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2024.

Based on FNY Investment Advisers's 13F filing for Q4 2024, filed 13 Jan 2025.